We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UTI:NYSEUniversal Technical Institute Inc Analysis

Data as of 2026-09-01 - not real-time

$21.13

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Universal Technical Institute, Inc. trades at $21.13, with its moving averages tangled rather than clearly stacked — a neutral trend structure. Across the trailing 30 sessions it lost 44.3%. With RSI at 25.0 the momentum picture is oversold, alongside a bullish MACD signal. Recent trading has carved out support near $20.74 and resistance around $43.61.
Multiples put this in fair territory at a P/E of 35.2. The average analyst target implies 98.0% above today's level. Revenue is growing at 7.2% on a 3.9% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 131.6%, a beta of 0.87 and a maximum drawdown of 58.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Revenue rises 7.2% to $218.9 million as new student starts surge, yet high school channel shortfall and skilled trades...UTI Investors Have Opportunity to Join Universal Technical Institute, Inc.Praetorian Capital, an investment management company, released its second-quarter 2026 investor letter.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 25.0 signals oversold conditions
  • Trading below the 200-day average of 33.48
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 25.0 signals oversold conditions
  • Trading below the 200-day average of 33.48
  • Analyst targets imply +98.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +98.0% versus the current price
  • Negative free cash flow
  • P/E ratio of 35.2

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin3.88%
P/E Ratio35.2
ROE10.53%
ROA3.46%
Debt/Equity104.41
P/B Ratio3.4
Op. Cash Flow$74.5M
Free Cash Flow$-4487750

Technical Analysis

TrendNeutral
RSI25.0
Support$20.74
Resistance$43.61
MA 20$26.09
MA 50$35.85
MA 200$33.48
MACDBullish
VolumeDecreasing
Fear & Greed Index93.04

Valuation

Fair Value$12.93
Target Price$41.83
Upside/Downside97.98%
GradeFair
TypeGrowth

Risk Assessment

Beta0.87
Volatility131.60%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.